196 related articles for article (PubMed ID: 20228595)
1. Medical management of primary hyperparathyroidism with concomitant multiple myeloma.
Fanari Z; Kadikoy H; Haque W; Pacha O; Abdellatif A
Intern Med; 2010; 49(6):581-4. PubMed ID: 20228595
[TBL] [Abstract][Full Text] [Related]
2. Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity.
Peacock M; Bilezikian JP; Bolognese MA; Borofsky M; Scumpia S; Sterling LR; Cheng S; Shoback D
J Clin Endocrinol Metab; 2011 Jan; 96(1):E9-18. PubMed ID: 20943783
[TBL] [Abstract][Full Text] [Related]
3. [Primary hyperparathyroidism: new concepts, new recommendations].
Crouzeix G; Kerlan V
Ann Endocrinol (Paris); 2014 Oct; 75 Suppl 1():S21-36. PubMed ID: 25617920
[TBL] [Abstract][Full Text] [Related]
4. Hypercalcemia of primary hyperparathyroidism was treated by cinacalcet in a patient with liver cirrhosis.
Akinci B; Comlekci A; Tankurt E
Exp Clin Endocrinol Diabetes; 2009 Mar; 117(3):142-5. PubMed ID: 18561096
[TBL] [Abstract][Full Text] [Related]
5. Cinacalcet for the treatment of primary hyperparathyroidism.
Dillon ML; Frazee LA
Am J Ther; 2011 Jul; 18(4):313-22. PubMed ID: 20228675
[TBL] [Abstract][Full Text] [Related]
6. Cinacalcet for hyperparathyroidism in pregnancy and puerperium.
Horjus C; Groot I; Telting D; van Setten P; van Sorge A; Kovacs CS; Hermus A; de Boer H
J Pediatr Endocrinol Metab; 2009 Aug; 22(8):741-9. PubMed ID: 19845125
[TBL] [Abstract][Full Text] [Related]
7. Medical management of primary hyperparathyroidism.
Khan AA
J Clin Densitom; 2013; 16(1):60-3. PubMed ID: 23374743
[TBL] [Abstract][Full Text] [Related]
8. Cinacalcet as alternative treatment for primary hyperparathyroidism: achievements and prospects.
Duntas LH; Stathatos N
Endocrine; 2011 Jun; 39(3):199-204. PubMed ID: 21442382
[TBL] [Abstract][Full Text] [Related]
9. Cinacalcet hydrochloride in combination with alendronate normalizes hypercalcemia and improves bone mineral density in patients with primary hyperparathyroidism.
Faggiano A; Di Somma C; Ramundo V; Severino R; Vuolo L; Coppola A; Panico F; Savastano S; Lombardi G; Colao A; Gasperi M
Endocrine; 2011 Jun; 39(3):283-7. PubMed ID: 21445714
[TBL] [Abstract][Full Text] [Related]
10. Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.
Khan A; Grey A; Shoback D
J Clin Endocrinol Metab; 2009 Feb; 94(2):373-81. PubMed ID: 19193912
[TBL] [Abstract][Full Text] [Related]
11. Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.
Del Prete M; Marotta V; Ramundo V; Marciello F; Di Sarno A; Esposito R; Carratù AC; De Luca Di Roseto C; Di Somma C; Colao A; Faggiano A
Minerva Endocrinol; 2013 Dec; 38(4):389-94. PubMed ID: 24285106
[TBL] [Abstract][Full Text] [Related]
12. Cognitive impairment reversed by cinacalcet administration in primary hyperparathyroidism.
Timmons JG; Manners R; Bailey M; McDougall C
Hormones (Athens); 2021 Sep; 20(3):587-589. PubMed ID: 33881757
[TBL] [Abstract][Full Text] [Related]
13. Management of Primary Hyperparathyroidism With Severe Hypercalcemia During the COVID-19 Pandemic.
Alfadhli EM
Clin Ther; 2021 Apr; 43(4):711-719. PubMed ID: 33752899
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic challenges in elderly patients with symptomatic hypercalcaemia caused by primary hyperparathyroidism.
Jacobs L; Samson MM; Verhaar HJ; Koek HL
Neth J Med; 2012 Jan; 70(1):35-8. PubMed ID: 22271812
[TBL] [Abstract][Full Text] [Related]
15. Update on the use of cinacalcet in the management of primary hyperparathyroidism.
Marcocci C; Cetani F
J Endocrinol Invest; 2012 Jan; 35(1):90-5. PubMed ID: 22104762
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of parathyroid levels and bone densitometry after cinacalcet treatment in severe primary hyperparathyroidism.
Ogrin C
Minerva Endocrinol; 2013 Sep; 38(3):337-8. PubMed ID: 24126554
[No Abstract] [Full Text] [Related]
17. [Low-dose cinacalcet reduces serum calcium in patients with primary hyperparathyroidism not eligible for surgery].
Arranz Martín A; Azcárate Villalón A; Luque Ramírez M; Santana Durán B; Marazuela Azpíroz M; Paniagua Ruiz A; Carraro R; Gómez Pan A
Endocrinol Nutr; 2011 Jan; 58(1):24-31. PubMed ID: 21277266
[TBL] [Abstract][Full Text] [Related]
18. Use of cinacalcet in nephrolithiasis associated with normocalcemic or hypercalcemic primary hyperparathyroidism: results of a prospective randomized pilot study.
Brardi S; Cevenini G; Verdacchi T; Romano G; Ponchietti R
Arch Ital Urol Androl; 2015 Mar; 87(1):66-71. PubMed ID: 25847900
[TBL] [Abstract][Full Text] [Related]
19. Cinacalcet-Associated Resolution of Primary Hyperparathyroidism in a Patient With Normal Kidney Function.
Nguyen S; Gosmanova EO; Gosmanov AR
J Investig Med High Impact Case Rep; 2020; 8():2324709620936836. PubMed ID: 32583691
[TBL] [Abstract][Full Text] [Related]
20. Transient hypercortisolism and symptomatic hyperthyroidism associated to primary hyperparathyroidism in an elderly patient: case report and literature review.
Sabbadin C; Donà G; Bordin L; Iacobone M; Camozzi V; Mian C; Armanini D
BMC Endocr Disord; 2015 Jan; 15():4. PubMed ID: 25631825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]